Blog

Miami, Florida, April 26, 2018 – ArisGlobal, a leading provider of integrated cloud-based software solutions for life sciences, today announced…

Top 5 life sciences organization joins forces with ArisGlobal to collaborate on the development of industry standard practices for cognitive platform for regulatory affairs and regulatory compliance.

Miami, Florida, April 12, 2018 –ArisGlobal, a leading provider of integrated cloud-based software solutions for life sciences, today announced that…

MIAMI, FL.  April 11, 2018 — ArisGlobal, LLC, a global leader in providing cloud-based software solutions for the life sciences,…

Miami, Florida, April 4th, 2018– ArisGlobal, a leading provider of an integrated, cloud-based suite of products with unmatched capabilities in solving the real-world research and development needs of life sciences organizations, today announced the expansion of its global offices and appointment of three key executives to the company’s management team.

Compliance with the new General Data Protection Regulation (GDPR), scheduled to become effective 25th May 2018, applies to all organizations that control or process personal data of European Union (EU) residents with or without a physical presence in the EU.

New EU regulation on data privacy, the General Protection Data Regulation, shines a Light on the benefits of automation to safeguard patient data when monitoring safety signals and ensuring pharmacovigilance databases can track changes to personal data and create an audit trail to remain GDPR compliant. Read the blog

ArisGlobal, LLC, a global leader in providing cloud-based software solutions for the life sciences, will present at the World Drug Safety Congress Americas 2018 conference to be held in Philadelphia, PA from April 10-11, 2018, on the topic “Automation is transforming pharmacovigilance. Is your organization ready?”

Whether companies like it or not, consumers are discussing their products in social media forums. Comments about adverse events exist on patient forums, and on more generic social forums such as Facebook and Twitter. While much of what is said is not relevant or verifiable, there are safety signals that companies should be paying attention to, and that go to the heart of pharmacovigilance and social media.

An integrated safety and pharmacovigilance software system with worldwide business processes helps companies realize significant productivity benefits. This position paper…